Testing glycosylated ferritin to evaluate inflammation
Part of Bones, joints & muscles, Immune system & allergy, Infections, Skin clinical trials.
This trial looks at a blood test called “glycosylated ferritin” to help doctors better identify certain dangerous inflammatory conditions. It may help clarify whether your high iron-related marker is due to inflammation rather than other causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Doctors suspect a serious infection (sepsis), macrophage activation syndrome, Still’s disease, or another cause of high ferritin.
- You have abnormal ferritin-related blood test results that prompted the suspicion.
- Your ferritin level is not normal (a normal ferritin result would likely exclude you).
- You will likely need blood samples for the study test (glycosylated ferritin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at two conditions in people who are critically ill (in intensive care): hyperinflammation (when the body's infection-fighting system overreacts) and hyperferritinemia (when a protein called ferritin is too high in the blood). It aims to understand these conditions better and may help improve care for critically ill patients.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This study looks at blood test “markers” to tell the difference between infection and non-infectious illness. It may help doctors recognize infection earlier and avoid confusion with other conditions.
This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
Hear when a new Still's Disease, Adult-Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.